Koch C, Hecker A, Grau V, Padberg W, Wolff M, Henrich M
Department of Anesthesiology and Intensive Care Medicine, University Hospital of Giessen and Marburg, 35392 Giessen, Germany.
Department General and Thoracic Surgery, University Hospital of Giessen and Marburg, 35392 Giessen, Germany.
Ann Med Surg (Lond). 2015 Aug 1;4(3):260-3. doi: 10.1016/j.amsu.2015.07.017. eCollection 2015 Sep.
Necrotizing fasciitis (NF) is an inflammatory disease of the soft tissue, which causes local tissue destruction and can lead to lethal septic shock. The therapy consists of early surgical treatment of the septic focus and an accompanying broad spectrum antibiotic therapy. Recent literature considers the additional use of immunoglobulin therapy in severe soft skin and tissue infections.
In this report, we describe the case of a 33-year-old male patient treated at a university hospital intensive care unit because of an NF of his left leg. The patient rapidly developed a complicated septic disease after a minor superficial trauma. Despite intense microbiological diagnosis, no causative pathogens were identified. After non-responding to established broad anti-infective treatment, the patient received intravenous immunoglobulin, that rapidly improved his clinical condition.
NF represents a disease processes, which is characterized by fulminant, widespread necrosis of soft tissue, systemic toxicity, and high mortality (>30%). Beside the surgical debridement and broad spectrum antibiotic therapy IVIg therapy might be an additional option in the treatment of NF. But the current literature supporting the use of IVIG in NF is largely based on retrospective or case-controlled studies, and only small randomized trials.
The demonstrated case suggests that IVIg treatment of patients with NF can be considered in case of hemodynamic unstable, critically ill patients. Although randomized controlled trials are missing, some patients might benefit from diminishing hyperinflammation by immunoglobins.
坏死性筋膜炎(NF)是一种软组织炎症性疾病,可导致局部组织破坏,并可能引发致命的感染性休克。治疗方法包括对感染灶进行早期手术治疗以及联合广谱抗生素治疗。近期文献认为在严重的皮肤和软组织感染中可额外使用免疫球蛋白治疗。
在本报告中,我们描述了一名33岁男性患者的病例,该患者因左腿坏死性筋膜炎在大学医院重症监护病房接受治疗。患者在一次轻微的浅表创伤后迅速发展为复杂的感染性疾病。尽管进行了深入的微生物学诊断,但未鉴定出致病病原体。在对既定的广泛抗感染治疗无反应后,患者接受了静脉注射免疫球蛋白治疗,其临床状况迅速改善。
坏死性筋膜炎是一种疾病过程,其特征为软组织迅速广泛坏死、全身毒性和高死亡率(>30%)。除了手术清创和广谱抗生素治疗外,静脉注射免疫球蛋白治疗可能是坏死性筋膜炎治疗的另一种选择。但目前支持在坏死性筋膜炎中使用静脉注射免疫球蛋白的文献主要基于回顾性或病例对照研究,且仅有小型随机试验。
该病例表明,对于血流动力学不稳定的危重症坏死性筋膜炎患者,可考虑静脉注射免疫球蛋白治疗。尽管缺乏随机对照试验,但一些患者可能会受益于免疫球蛋白减轻过度炎症反应。